Gelonghui, May 10, 丨 Tong Ren Tang Sinopharm (03613.HK) announced that Mr. Wang Chi was appointed as the company's executive director, CEO and member of the Competition Executive Committee, effective May 10, 2024.
The board of directors further announced that since Mr. Wang was appointed as the company's CEO, Mr. Chen Fei, executive director, acting CEO and executive deputy general manager of the company will no longer serve as acting CEO. Effective May 10, 2024, he will continue to serve as the company's executive director and executive deputy general manager.